Identifying risks of heart failure and cognitive decline in people with type 2 diabetes
Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes : Longitudinal Cohort Study of Immuno-inflammation, Cardiac Energetics and Cognition.PreciDIAB-HEART&BRAIN
This study is trying to find out which adults with type 2 diabetes might be at risk for heart failure and memory problems so that they can get early help.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 1 site (Lille) |
| Trial ID | NCT04583800 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify patients with type 2 diabetes who are at risk of developing heart failure and cognitive decline. By focusing on early detection, the study seeks to develop personalized preventive strategies for these conditions. Participants will be adults with type 2 diabetes who do not have heart failure at stage B or dementia. The study will gather data to better understand the relationship between diabetes and these serious health issues.
Who should consider this trial
Good fit: Ideal candidates for this study are adults with type 2 diabetes who are free of heart failure at stage B.
Not a fit: Patients with dementia or those who already meet criteria for heart failure at stage B will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to targeted prevention strategies for heart failure and cognitive decline in diabetic patients.
How similar studies have performed: While the approach of identifying risks in diabetic patients is established, the specific focus on early heart failure and cognitive decline in this context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults * Persons able to understand and object to the information provided. * Type 2 diabetic patient free of heart failure ≥stade B * Patient affiliated with a social security scheme. * Patient agreeing to sign the informed consent form Exclusion Criteria: * Patient with dementia * Patient with at least one of the criteria for heart failure ≥stade B
Where this trial is running
Lille
- Hopital Roger Salengro, CHU Lille — Lille, France (Recruiting)
Study contacts
- Principal investigator: Charlotte Cordonnier, MD,PhD — University Hospital, Lille
- Study coordinator: Charlotte Cordonnier, MD,PhD
- Email: precidiab_heart_brain@chru-lille.fr
- Phone: 0320445962
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.